Articles

Why it could be time for biopharma leaders to embrace data analytics

Siobhan Fleming, business development manager at Siemens, discusses how and why biopharma companies can benefit from data analytics. Is it time for biopharma to follow in the footsteps of sectors such as telecoms, advertising and insurance in embracing data analytics?

We spoke to Siemens business development manager Siobhan Fleming to learn more. Can you explain what your current job involves? I joined Siemens Digital Industries in March this year to manage the business development activities for BioMAC. BioMAC is our advanced big data analytics solution for biopharma – it is supported by the IDA and has been developed in collaboration with the National Institute for Bioprocessing Research and Training (NIBRT).

Source: siliconrepublic.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s